MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with I

Indapamide

Indapamide 1.5mg modified-release tablets

Use with caution

Stability notes for Indapamide 1.5mg modified-release tablets

Store in airtight containers. Protect from light and maximum 8 days in MCA.

Provenance

This compatibility recommendation is derived from Natrilix SR 1.5mg tablets (Servier Laboratories Ltd).

Suppliers (8) of Indapamide 1.5mg modified-release tablets
Alkapamid XL 1.5mg tablets (HBS Healthcare Ltd)
Cardide SR 1.5mg tablets (Teva UK Ltd)
Indapamide 1.5mg modified-release tablets (Krka UK Ltd)
Indapamide 1.5mg modified-release tablets (Teva UK Ltd)
Lorvacs XL 1.5mg tablets (Torrent Pharma (UK) Ltd)
Natrilix SR 1.5mg tablets (Necessity Supplies Ltd)
Natrilix SR 1.5mg tablets (Servier Laboratories Ltd)
Natrilix SR 1.5mg tablets (Sigma Pharmaceuticals Plc)

Indapamide 2.5mg tablets

Use with caution

Stability notes for Indapamide 2.5mg tablets

Protect from light. Store in airtight containers.

Provenance

This compatibility recommendation is derived from Natrilix 2.5mg tablets (Servier Laboratories Ltd).

Suppliers (11) of Indapamide 2.5mg tablets
Indapamide 2.5mg tablets (A A H Pharmaceuticals Ltd)
Indapamide 2.5mg tablets (Accord-UK Ltd)
Indapamide 2.5mg tablets (Alliance Healthcare (Distribution) Ltd)
Indapamide 2.5mg tablets (Almus Pharmaceuticals Ltd)
Indapamide 2.5mg tablets (Medihealth (Northern) Ltd)
Indapamide 2.5mg tablets (Niche Generics Ltd)
Indapamide 2.5mg tablets (Phoenix Healthcare Distribution Ltd)
Indapamide 2.5mg tablets (RX Farma)
Indapamide 2.5mg tablets (Sigma Pharmaceuticals Plc)
Indapamide 2.5mg tablets (Strides Pharma UK Ltd)
Indapamide 2.5mg tablets (Zentiva Pharma UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.